Novo Nordisk and Eli Lilly are major players in the weight loss market, but their dominance has recently weakened. What's happening to them? The Swiss investor website Cash.ch wonders.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Novo Nordisk and Eli Lilly are major players in the weight loss market, but their dominance has recently weakened. What's happening to them? The Swiss investor website Cash.ch wonders.